# LIQREV
> **NDA214952** · New Drug Application · Sponsor: CMP DEV LLC · Approved 2023-04-28
## Drug
- **FDA Application Number:** NDA214952
- **Application type:** New Drug Application
- **Brand name:** LIQREV
- **Generic name:** Sildenafil Citrate
- **Active ingredients:** SILDENAFIL CITRATE
- **Dosage form:** SUSPENSION
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** CMP DEV LLC
- **First approval:** 2023-04-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214952)
---
*AI Analytics · CC0 1.0*